[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CurrentPartnering: Market Research Reports

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Publications found: 68
Sort by:

Companion Diagnostic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Case studies of real-life Companion Diagnostics deals Access to Companion Diagnostics contract documents Leading Companion Diagnostics deals by value since 2014 Most active Companion Diagnostics dealmakers since 2014 In Global Companion Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2023 100 pages

Bioinformatic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2014 ...

November 2023 600 pages

Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

November 2023 300 pages

Antibody Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...

November 2023 950 pages

Antibiotic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...

November 2023 100 pages

Cancer Diagnostic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2023 450 pages

Regenerative Medicine Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. DESCRIPTION The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players ...

November 2023 950 pages

Diagnostic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... healthcare sectors, covering: Companion Diagnostics Imaging CT Endoscope Molecular and nuclear MRI Ultrasound X-ray PET SPECT Angiography Fluroscopy Mammography In vitro diagnostics Molecular diagnostics Prognostics Theranostics The report provides a detailed ...

November 2023 1000 pages

Monoclonal Antibody Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Access to over 640 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2014 Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014 In Global Monoclonal antibody Partnering Terms and Agreements 2014 to 2098 ...

November 2023 500 pages

Vaccine Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...

November 2023 400 pages

Drug Delivery Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Drug Delivery deals Access to Drug Delivery contract documents Leading Drug Delivery deals by value since 2014 Most active Drug Delivery dealmakers since 2014 In Global Drug Delivery Partnering 2014-2019: Deal ... at signing Deal component type Specific therapy target Technology type Each deal title links ...

November 2023 850 pages

Diagnostic Imaging Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...

November 2023 300 pages

Gene Therapy Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... -life gene therapy deals Access to over 220 gene therapy deals The leading gene therapy deals by value since 2014 Most active gene therapy dealmakers since 2014 The leading gene therapy partnering resources In Global Gene Therapy Partnering Terms and ...

November 2023 450 pages

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... 250 infectious vaccines deal records Identify the most active infectious vaccine dealmakers since 2014 The leading infectious vaccines deals by value since 2014 Includes adjuvant deals and alliances since 2014 In Global Infectious Vaccines Partnering Terms ...

November 2023 300 pages

In Vitro Diagnostic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... of real-life In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2014 Most active In Vitro Diagnostics dealmakers since 2014 In Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players ...

November 2023 150 pages

Molecular Diagnostics Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... due diligence to assess suitability of your proposed deal terms for partner companies Report scope Global Molecular Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts is intended ...

November 2023 400 pages

Stem Cell Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Case studies of real-life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2014 Most active Stem Cell dealmakers since 2014 In Global Stem Cell Partnering 2014-2019: Deal trends, players, financials and ...

November 2023 100 pages

Genomic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... , upfronts, milestones and royalties by stage of development Genomics partnering contract documents Top Genomics deals by value The Global Genomics Partnering Terms and Agreements report provides an understanding and ...

November 2023 450 pages

Microbiome Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... , upfronts, milestones and royalties by stage of development Microbiome partnering contract documents Top Microbiome deals by value The Global Microbiome Partnering Terms and Agreements report provides an understanding and ...

November 2023 200 pages

Artificial Intelligence (AI) Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... 200 artificial intelligence deals The leading artificial intelligence deals by value since 2014 Most active artificial intelligence dealmakers since 2014 The leading artificial intelligence partnering resources In Global Artificial Intelligence Partnering Terms and ...

November 2023 450 pages

Precision Medicine Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding ...

November 2023 900 pages

Biomarker Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

SUMMARY Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research d...

November 2023 300 pages

Gene Editing Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

SUMMARY Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and researc...

November 2023 200 pages

Viral Vector Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

SUMMARY Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and researc...

November 2023 250 pages

Cell Therapy Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

SUMMARY Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and researc...

November 2023 450 pages

Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

SUMMARY Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, develo...

November 2023 450 pages

Cardiovascular Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

October 2023 300 pages

Psychiatry Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Psychiatry Partnering 2014 to 2019 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Psychiatry partnering deals Financial deal terms ...

October 2023 400 pages

Infectious Diseases Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION Global Infectious Diseases Partnering 2014 to 2019 provides the full collection of Infectious Diseases disease deals signed between ...

October 2023 1000 pages

Hematology Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hematology partnering deals Financial deal terms ...

October 2023 100 pages

Central Nervous System Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig ...

October 2023 650 pages

Gastrointestinal Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... , Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation ...

October 2023 200 pages

Genitourinary Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Genitourinary Partnering 2014 to 2019 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genitourinary partnering deals Financial deal terms ...

October 2023 150 pages

Gynecology Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... scope Global Gynecology Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Gynecology trends and structure of deals entered into by leading companies worldwide. Global Gynecology Partnering 2014 to 2019 ...

October 2023 100 pages

Immunology Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Immunology Partnering 2014 to 2019 provides the full collection of Immunology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Immunology partnering deals Financial deal terms ...

October 2023 450 pages

Metabolic Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Metabolic Partnering 2014 to 2019 provides the full collection of Metabolic disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Metabolic partnering deals Financial deal terms ...

October 2023 450 pages

Respiratory Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Respiratory Partnering 2014 to 2019 provides the full collection of Respiratory disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Respiratory partnering deals Financial deal terms ...

October 2023 200 pages

Musculoskeletal Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Musculoskeletal Partnering 2014 to 2019 provides the full collection of Musculoskeletal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Musculoskeletal partnering deals Financial deal terms ...

October 2023 250 pages

Oncology Collaboration and Licensing Deals 2019-2023

US$ 3,995.00

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

October 2023 1600 pages

Dermatology Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

October 2023 250 pages

Hospital Care Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... access to Hospital Care trends and structure of deals entered into by leading companies worldwide. Global Hospital Care Partnering 2014 to 2019 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2014 Analysis of Hospital Care deal structure ...

October 2023 350 pages

Ophthalmics Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... DESCRIPTION Global Ophthalmics Partnering 2014 to 2019 provides the full collection of Ophthalmics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal terms ...

October 2023 250 pages

Autoimmune Collaboration and Licensing Deals 2016-2023

US$ 3,995.00

... autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma ...

October 2023 450 pages

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2023

US$ 3,995.00

... the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies REPORT SCOPE Global Asset Purchase Deals in Pharma, Biotech and ...

September 2023 300 pages

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2023

US$ 3,995.00

... manufacturing and supply deals by value since 2014 Most active manufacturing and supply dealmakers since 2014 The leading manufacturing and supply partnering resources In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech ...

September 2023 600 pages

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2023

US$ 3,995.00

... Current Agreements deals and alliances database, providing easy access to each deal record on demand. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 ...

September 2023 200 pages

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2023

US$ 3,995.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

September 2023 350 pages

Collaboration Deals in Pharmaceuticals 2019-2023

US$ 3,995.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

September 2023 1000 pages

Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2023

US$ 3,995.00

... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...

September 2023 500 pages

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2023

US$ 3,995.00

... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...

September 2023 200 pages

Filters

Search

Categories

23
4
2
1
1
1
1
1
1
6
2
1
1
16
4
3

Publishers

68

Regions

68

Price

Date

Pages

Offers